II
AXSM icon

Ishara Investments’s Axsome Therapeutics AXSM Stock Holding History

Ishara Investments’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.01M Sell
16,400
-24,600
-60% -$5.33M 2.95% 15
2026
Q1 		$6.93M Buy
+41,000
New +$7.08M 6.56% 2

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Ishara Investments's AXSM Position: Q2 2026 in Review

Ishara Investments reduced its Axsome Therapeutics (AXSM) stake by 60% in Q2 2026, selling an estimated $5.33M and leaving 16,400 shares worth $4.01M. The position accounts for 2.95% of the portfolio, ranked #15.

Ishara Investments first reported a position in AXSM in Q1 2026 and has held it in 2 quarters since. The position peaked at $6.93M in Q1 2026. 504 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Ishara Investments held 16,400 shares of Axsome Therapeutics worth $4.01M as of Q2 2026.
  • Ishara Investments sold 24,600 Axsome Therapeutics shares in Q2 2026, an estimated $5.33M.
  • Axsome Therapeutics made up 2.95% of Ishara Investments's portfolio in Q2 2026, its #15 holding.
  • Ishara Investments first reported a position in Axsome Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Ishara Investments's Axsome Therapeutics position peaked at $6.93M in Q1 2026.
  • 504 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Ishara Investments's 13F filing for Q2 2026, filed 14 Aug 2026.